ALSO further strengthens expertise
» Report
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Alle Kategorien
ALSO baut Kompetenz weiter aus
» Report
Novartis receives priority review by US FDA and filing acceptance by EMA for Kymriah® to treat patients with relapsed or refractory follicular lymphoma
» Report
Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function
» Report
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Positive Interim Data from Its Clinical Trial of Novel Nasal Spray Sentinox in SARS-CoV-2 Infected Patients
» Report
Sulzer: Starker Bestellungseingang, Guidance bestätigt
» Report
Sulzer: Strong orders, guidance confirmed
» Report
Achiko réalise les premières ventes du test de diagnostic AptameX Covid-19
» Report
Achiko AG: Achiko secures initial sales of AptameX Covid-19 diagnostic test
» Report
Achiko vermeldet ersten Verkaufsauftrag für Covid-19-Dignosetest AptameX
» Report
Bossard Capital Markets Day 2021: Successful implementation of Strategy 200 boosts medium-term financial goals
» Report
Bossard Capital Markets Day 2021: Erfolgreiche Umsetzung der Strategie 200 führt zur Erhöhung der mittelfristigen Finanzziele
» Report
Dätwyler mit Gewinn aus Verkauf von Reichelt.
» Report
Datwyler with gain on sale of Reichelt.
» Report
Datacolor fiscal 2020/21
» Report
Datacolor im Geschäftsjahr 2020/21
» Report
SGS: Withdrawal of Temporary Hand Sanitizer Policies in the USA
» Report
SGS: China Releases Supervision and Administration Provisions on Children’s Cosmetics
» Report
SGS Opens New State-of-the-Art Site for Clinical Research in Antwerp, Belgium
» Report
DAILY SMI +0,69% 12'146 A/D 5:4 SMI Top SREN +2,7% SLHN +2.1% CFR +1,8% ZURN +1,5% UBSG +1,25% CSGN +1,1%
Flop LOGN -4,3% SIKA -0,35% SGSN -0,3% GEBN -0,2% ROG +0,2% GIVN +0,4%
+++ VSMI -3,42% 12.58 (13.02) +++ DAX +1,01%% 15'757 +++ Strasse freundlich
